Revolution Medicines: Positioning Itself To Capture One Of The Largest Cancer Targets In History

In covering Revolution Medicines (NASDAQ: RVMD ) I've grown more and more confident based on what I've seen, particularly coming out of the ASCO GI meeting this past January. I andI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this space.Analyst’s ...